Fibroblasts in cancer: Unity in heterogeneity

Y Chhabra, AT Weeraratna - Cell, 2023 - cell.com
Tumor cells do not exist in isolation in vivo, and carcinogenesis depends on the surrounding
tumor microenvironment (TME), composed of a myriad of cell types and biophysical and …

KRAS mutation: from undruggable to druggable in cancer

L Huang, Z Guo, F Wang, L Fu - Signal transduction and targeted …, 2021 - nature.com
Cancer is the leading cause of death worldwide, and its treatment and outcomes have been
dramatically revolutionised by targeted therapies. As the most frequently mutated oncogene …

Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer

F Wu, J Yang, J Liu, Y Wang, J Mu, Q Zeng… - Signal transduction and …, 2021 - nature.com
To flourish, cancers greatly depend on their surrounding tumor microenvironment (TME),
and cancer-associated fibroblasts (CAFs) in TME are critical for cancer occurrence and …

Immune modulatory effects of oncogenic KRAS in cancer

S Hamarsheh, O Groß, T Brummer, R Zeiser - Nature communications, 2020 - nature.com
Oncogenic KRAS mutations are the most frequent mutations in human cancer, but most
difficult to target. While sustained proliferation caused by oncogenic KRAS-downstream …

Pancreatic tumor microenvironment factor promotes cancer stemness via SPP1–CD44 axis

P Nallasamy, RK Nimmakayala, S Karmakar, F Leon… - Gastroenterology, 2021 - Elsevier
Background & Aims Tumor-microenvironment factors and cancer stem cells (CSCs) play a
critical role in the aggressiveness of pancreatic cancer (PC). However, the degree to which …

CXCR2 receptor: regulation of expression, signal transduction, and involvement in cancer

J Korbecki, P Kupnicka, M Chlubek, J Gorący… - International Journal of …, 2022 - mdpi.com
Chemokines are a group of about 50 chemotactic cytokines crucial for the migration of
immune system cells and tumor cells, as well as for metastasis. One of the 20 chemokine …

MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer

S Casacuberta-Serra, Í González-Larreategui… - … and Targeted Therapy, 2024 - nature.com
RAS and MYC rank amongst the most commonly altered oncogenes in cancer, with RAS
being the most frequently mutated and MYC the most amplified. The cooperative interplay …

[HTML][HTML] Unveiling the role of KRAS in tumor immune microenvironment

M Xu, X Zhao, T Wen, X Qu - Biomedicine & Pharmacotherapy, 2024 - Elsevier
Kirsten rats sarcoma viral oncogene (KRAS), the first discovered human oncogene, has long
been recognized as “undruggable”. KRAS mutations frequently occur in multiple human …

Determinants and functions of CAFs secretome during cancer progression and therapy

J Linares, JA Marín-Jiménez… - Frontiers in cell and …, 2021 - frontiersin.org
Multiple lines of evidence are indicating that cancer development and malignant
progression are not exclusively epithelial cancer cell-autonomous processes but may also …

Roles of the CXCL8-CXCR1/2 axis in the tumor microenvironment and immunotherapy

ZJ Han, YB Li, LX Yang, HJ Cheng, X Liu, H Chen - Molecules, 2021 - mdpi.com
In humans, Interleukin-8 (IL-8 or CXCL8) is a granulocytic chemokine with multiple roles
within the tumor microenvironment (TME), such as recruiting immunosuppressive cells to the …